104 related articles for article (PubMed ID: 6296172)
21. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.
Emini EA; Jameson BA; Wimmer E
Nature; 1983 Aug 25-31; 304(5928):699-703. PubMed ID: 6310403
[TBL] [Abstract][Full Text] [Related]
22. Intratypic differentiation of poliovirus strains by enzyme-linked immunosorbent assay (ELISA): poliovirus type 2 and poliovirus type 3.
Glikmann G; Pedersen M; Petersen I
J Virol Methods; 1987 Oct; 18(1):25-36. PubMed ID: 2826518
[TBL] [Abstract][Full Text] [Related]
23. Structural studies of virus-antibody immune complexes (poliovirus type I): Characterization of the epitopes in 3D.
Bannwarth L; Girerd-Chambaz Y; Arteni AA; Guigner JM; Lemains J; Ronzon F; Manin C; Vénien-Bryan C
Mol Immunol; 2015 Feb; 63(2):279-86. PubMed ID: 25146483
[TBL] [Abstract][Full Text] [Related]
24. Anti-idiotypic antibodies to poliovirus antibodies in commercial immunoglobulin preparations, human serum, and milk.
Hahn-Zoric M; Carlsson B; Jeansson S; Ekre HP; Osterhaus AD; Roberton D; Hanson LA
Pediatr Res; 1993 May; 33(5):475-80. PubMed ID: 8390047
[TBL] [Abstract][Full Text] [Related]
25. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
26. A competition immunoprecipitation assay of unlabeled poliovirus antigens.
Rombaut B; Jore J; Boeyé A
J Virol Methods; 1994 Jun; 48(1):73-9. PubMed ID: 7962262
[TBL] [Abstract][Full Text] [Related]
27. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
28. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
Rezapkin G; Martin J; Chumakov K
Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
[TBL] [Abstract][Full Text] [Related]
29. A simple quantitative protein A micro-immunoprecipitation method; assay of antibodies to the N and H antigens of poliovirus.
Vrijsen R; Rombaut B; Boeyé A
J Immunol Methods; 1983 Apr; 59(2):217-20. PubMed ID: 6302166
[TBL] [Abstract][Full Text] [Related]
30. Strain differentiation of polioviruses with monoclonal antibodies.
Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
[TBL] [Abstract][Full Text] [Related]
31. Mapping of the epitopes of poliovirus type 2 in complex with antibodies.
Bannwarth L; Girerd-Chambaz Y; Arteni A; Guigner JM; Ronzon F; Manin C; Vénien-Bryan C
Mol Immunol; 2015 Oct; 67(2 Pt B):233-9. PubMed ID: 26059753
[TBL] [Abstract][Full Text] [Related]
32. [Monoclonal antibodies used to differentiate between poliovirus types 1 and 3].
Shirobokov VP; Kopanitsa LV; Nikolaenko IV; Lipatnikova KI; Sologub VK
Mikrobiol Z; 2001; 63(6):42-52. PubMed ID: 11944335
[TBL] [Abstract][Full Text] [Related]
33. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
34. A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
Thomas AA; Brioen P; Boeyé A
J Virol; 1985 Apr; 54(1):7-13. PubMed ID: 2983121
[TBL] [Abstract][Full Text] [Related]
35. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
[TBL] [Abstract][Full Text] [Related]
36. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
[TBL] [Abstract][Full Text] [Related]
37. [Utilization of an ELISA technic for the quantification of antipoliovirus antibodies in human sera].
Gershy-Damet GM; Koffi KJ
Bull Soc Pathol Exot Filiales; 1987; 80(3):289-94. PubMed ID: 3040283
[TBL] [Abstract][Full Text] [Related]
38. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
Moynihan M; Ladefoged P; Mathiesen L
Dev Biol Stand; 1980; 46():203-6. PubMed ID: 6244998
[TBL] [Abstract][Full Text] [Related]
39. Hit-and-run neutralization of poliovirus.
Brioen P; Rombaut B; Boeyé A
J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
[TBL] [Abstract][Full Text] [Related]
40. Immunoradiometric assay for cytomegalovirus-specific IgG antibodies: assay development and evaluation in blood transfusion practice.
Klapper PE; Cleator GM; Prinja-Wilks D; Morris DJ; Morrell G
J Virol Methods; 1990 Mar; 27(3):327-39. PubMed ID: 2157732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
